📚 Biology Paper 1: Experimental Design for MS Research | 生物 Paper 1：多发性硬化症实验设计
Experimental design is a cornerstone of Biology Paper 1, requiring you to apply scientific methodology to novel scenarios. This article uses multiple sclerosis (MS) as a context to unpack how to structure a rigorous investigation, from hypothesis to evaluation, helping you secure top marks in any ‘design an experiment’ question.
实验设计是生物学 Paper 1 的核心，要求你将科学方法应用于全新的情境。本文以多发性硬化症（MS）为背景，解构如何从假设到评估构建严谨的研究，帮助你在任何“设计实验”题目中斩获高分。
1. Understanding Multiple Sclerosis and Research Goals | 了解多发性硬化症与研究目标
Multiple sclerosis is a chronic autoimmune disease where the immune system attacks the myelin sheath of neurons in the central nervous system, leading to impaired nerve conduction. Research goals often include identifying triggers, testing the efficacy of potential treatments, or understanding the mechanisms of demyelination and remyelination.
多发性硬化症是一种慢性自身免疫疾病，免疫系统攻击中枢神经系统神经元的髓鞘，导致神经传导受损。研究目标通常包括确定触发因素、测试潜在治疗方法的功效，或理解脱髓鞘和髓鞘再生的机制。
Before designing an experiment, you must define a clear aim, such as “to investigate whether Compound X reduces clinical severity in an MS mouse model.” This sharp focus guides every subsequent choice.
在设计实验之前，你必须明确目标，例如“研究化合物 X 是否能降低 MS 小鼠模型的临床严重程度”。这种清晰的焦点会指导随后的每一个选择。
2. Formulating a Testable Research Question | 提出可测试的研究问题
A strong research question is specific, measurable, and feasible. For instance: “Does daily administration of 10 mg/kg of Drug Y reduce the number of inflammatory lesions in the spinal cord of EAE mice compared to a saline control over 28 days?” It identifies the intervention, the outcome, the comparator, and the time frame.
一个有力的研究问题是具体的、可测量的和可行的。例如：“与生理盐水对照组相比，连续 28 天每天给予 10 mg/kg 的药物 Y 是否能减少 EAE 小鼠脊髓中的炎性病灶数量？”它明确了干预措施、结果、对照和时间框架。
In Paper 1, you may be given a scenario and asked to suggest a hypothesis. Always frame it as a predictive statement, not a general inquiry.
在 Paper 1 中，你可能会得到一个情境并被要求提出假设。始终将其构建为一个预测性陈述，而非一般性的询问。
3. Developing a Null and Alternative Hypothesis | 建立零假设与备择假设
The null hypothesis (H0) states there is no effect or difference, e.g., “There is no significant difference in the mean clinical score between EAE mice treated with Drug Y and those receiving saline.” The alternative hypothesis (H1) predicts a directional or non-directional effect, e.g., “Mice treated with Drug Y will have a significantly lower mean clinical score.”
零假设（H0）陈述没有效应或差异，例如“接受药物 Y 治疗的 EAE 小鼠与接受生理盐水的小鼠之间的平均临床评分没有显著差异。”备择假设（H1）则预测一个有方向性或无方向性的效应，例如“药物 Y 治疗的小鼠平均临床评分显著更低。”
This dual framing is essential for statistical testing later. In your answer, clearly state both hypotheses using operationalised variables.
这种双重框架对于之后的统计检验至关重要。在你的答案中，要用可操作的变量清晰地陈述两个假设。
4. Selecting an Appropriate Experimental Model | 选择恰当的实验模型
For MS research, the experimental autoimmune encephalomyelitis (EAE) mouse model is widely used because it mimics key features of MS, including T-cell infiltration and demyelination. You must justify your choice: “EAE mice develop reproducible clinical symptoms, allowing us to quantify disease progression using a standardised scoring scale.”
对于 MS 研究，实验性自身免疫性脑脊髓炎（EAE）小鼠模型被广泛使用，因为它模拟了 MS 的关键特征，包括 T 细胞浸润和脱髓鞘。你必须为你的选择提供理由：“EAE 小鼠会产生可重复的临床症状，使我们能够使用标准化的评分量表来量化疾病进展。”
Alternatively, in vitro models such as oligodendrocyte cultures can be used to study remyelination mechanisms. Select the model that best matches your research question.
或者，诸如少突胶质细胞培养等体外模型可用于研究髓鞘再生的机制。应选择最符合你研究问题的模型。
5. Identifying Independent, Dependent, and Control Variables | 识别自变量、因变量和控制变量
The independent variable (IV) is what you manipulate, e.g., the dose of Drug Y (0 mg/kg, 5 mg/kg, 10 mg/kg). The dependent variable (DV) is what you measure, e.g., the clinical score assessed daily on a 0-5 scale. Controlled variables (CVs) must be kept constant to ensure validity, such as age, sex, housing conditions, and induction protocol of EAE.
自变量（IV）是你操纵的因素，例如药物 Y 的剂量（0 mg/kg、5 mg/kg、10 mg/kg）。因变量（DV）是你测量的指标，例如每天用 0-5 分制评估的临床评分。控制变量（CVs）必须保持恒定以确保效度，例如年龄、性别、饲养条件和 EAE 的诱导方案。
In your design, list at least three controlled variables with specific details: “All mice were female C57BL/6, aged 8-10 weeks, housed at 22 °C with a 12-hour light/dark cycle.” This demonstrates precision.
在你的设计中，列出至少三个带有具体细节的控制变量：“所有小鼠均为雌性 C57BL/6，8-10 周龄，在 22 °C 温度和 12 小时明/暗周期下饲养。”这展示了精确性。
6. Structuring Experimental Groups and Controls | 构建实验组与对照组
A robust design includes negative controls (e.g., saline-treated EAE mice) and positive controls (e.g., a known immunosuppressant like dexamethasone) alongside your experimental groups. This allows you to attribute any observed effect specifically to the independent variable and verify that the model is working.
一个稳健的设计除了实验组之外，还包括阴性对照（例如生理盐水处理的 EAE 小鼠）和阳性对照（例如已知的免疫抑制剂如地塞米松）。这让你能将任何观察到的效应专门归因于自变量，并验证模型是否正常工作。
Random allocation of subjects to groups minimises selection bias. Always state that mice were ‘randomly assigned’ to each treatment group using a random number generator.
将受试对象随机分配到各组可最大限度减少选择偏倚。始终说明小鼠是使用随机数字生成器“随机分配”到各处理组的。
7. Determining Sample Size and Replication | 确定样本量与重复
Sample size (n) should be based on a power analysis from prior studies to detect a biologically meaningful difference. For an EAE experiment, a typical power calculation might yield n=10 per group to account for variability in disease induction. State your n and justify it: “Using n=10 per group provides 80% power to detect a 30% reduction in clinical score at p<0.05, based on published data."
样本量（n）应基于先前研究的功效分析，以检测出具有生物学意义的差异。对于 EAE 实验，一个典型的功效计算可能得出每组 n=10 以考虑疾病诱导的变异性。说明你的 n 并给出理由：“根据已发表数据，每组 n=10 可提供 80% 的统计功效，以 p<0.05 检测出临床评分降低 30%。”
Replication means repeating the whole experiment at least three times or using multiple cohorts to confirm reproducibility. Without replication, results may be anecdotal.
重复是指至少重复整个实验三次或使用多个批次以确认可重复性。没有重复，结果可能是偶然的。
8. Planning Data Collection and Measurement | 规划数据收集与测量
Specify exactly how you will measure the dependent variable. In MS models, common methods include: daily clinical scoring (0=no disease, 5=moribund), histological analysis of spinal cord sections stained with Luxol fast blue to quantify demyelination, and ELISA to measure pro-inflammatory cytokines (e.g., IL-17, IFN-γ) in serum.
精确说明你将如何测量因变量。在 MS 模型中，常用方法包括：每日临床评分（0=无疾病，5=濒死），对用坚牢蓝染色的脊髓切片进行组织学分析以定量脱髓鞘，以及 ELISA 测量血清中的促炎细胞因子（如 IL-17、IFN-γ）。
Use a table to summarise the timeline:
| Day | Procedure |
|---|---|
| 0 | EAE induction by MOG₃₅₋₅₅ peptide injection |
| 7-35 | Daily Drug Y/saline administration; clinical scoring |
| 35 | Sacrifice, tissue collection, histology, ELISA |
Always include instrumental precision, e.g., “clinical scores recorded by two independent observers blinded to treatment groups to reduce observer bias.”
始终要包含仪器精度，例如“临床评分由两名对处理分组不知情的独立观察者记录，以减少观察者偏差。”
9. Incorporating Ethical Considerations | 纳入伦理考量
Any animal experiment must adhere to the 3Rs: Replacement, Reduction, and Refinement. Specify humane endpoints, e.g., “Mice losing more than 20% of body weight or reaching a clinical score of 4 were euthanised to minimise suffering.” Also mention approval from an institutional animal ethics committee.
任何动物实验都必须遵守 3R 原则：替代、减少和优化。具体说明人道终点，例如“体重下降超过 20% 或临床评分达到 4 分的小鼠将被安乐死，以尽量减少痛苦。”还要提及已获得机构动物伦理委员会的批准。
In a written answer, you might note: “All procedures complied with the Animals (Scientific Procedures) Act 1986 and were conducted under a Home Office licence.”
在书面答案中，你可以注明：“所有程序符合 1986 年《动物（科学程序）法》，并在内政部许可证下进行。”
10. Choosing a Statistical Analysis Plan | 选择统计分析方案
Select an appropriate test based on your data type. For ordinal clinical scores across multiple time points, a two-way repeated measures ANOVA followed by a post-hoc test (e.g., Tukey’s) is suitable. If comparing a single endpoint such as lesion area, a one-way ANOVA or Kruskal-Wallis test (if data are non-parametric) may be used.
根据你的数据类型选择恰当的检验。对于跨越多个时间点的有序临床评分，双向重复测量方差分析继以事后检验（如 Tukey 检验）是合适的。如果比较单个终点如病灶面积，可使用单向方差分析或 Kruskal-Wallis 检验（若数据为非参数）。
State your significance level (α=0.05) and that results will be presented as mean ± SEM. Always justify why the test is appropriate, linking back to the hypothesis.
说明你的显著性水平（α=0.05），并说明结果将以均值 ± 标准误的形式呈现。始终解释为何该检验是恰当的，并与假设相联系。
11. Interpreting Results and Drawing Conclusions | 解读结果并得出结论
Anticipate possible outcomes. If the p-value is <0.05 and the means differ as predicted, reject the null hypothesis and conclude that Drug Y significantly reduces clinical severity in the EAE model. However, note that correlation does not imply causation; consider confounding factors.
预测可能的结果。若 p 值 <0.05 且均值如预测般存在差异，则拒绝零假设并得出结论：在 EAE 模型中，药物 Y 显著降低临床严重程度。然而，需注意相关性并不意味着因果关系；要考虑混杂因素。
If the result is not significant, discuss possible reasons: insufficient sample size, dosage issues, or variability in disease induction. Never conclude “the drug has no effect” without acknowledging limitations.
若结果不显著，讨论可能的原因：样本量不足、剂量问题或疾病诱导的变异性。在未承认局限性的情况下，永远不要得出“该药物无效”的结论。
12. Evaluating Strengths and Limitations | 评估优势与局限性
Every experimental design should end with a critical evaluation. Strengths of the above design include blinding, randomisation, standardised scoring, and use of both negative and positive controls, which enhance internal validity.
每个实验设计都应以批判性评估收尾。上述设计的优势包括盲法、随机化、标准化评分以及使用阴性和阳性对照，这些增强了内部效度。
Limitations might be: the EAE model does not fully recapitulate human MS, the sample size may be too small to detect subtle effects, and in vitro findings may not translate in vivo. Suggest future improvements, such as testing additional doses or using a transgenic mouse model.
局限性可能包括：EAE 模型并不能完全重现人类 MS，样本量可能过小而无法检测细微效应，以及体外研究结果可能无法推至体内。提出未来的改进方向，例如测试更多剂量或使用转基因小鼠模型。
Published by TutorHao | Biology Revision Series | aleveler.com
更多咨询请联系16621398022（同微信）
屏轩国际教育cambridge primary/secondary checkpoint, cat4, ukiset,ukcat,igcse,alevel,PAT,STEP,MAT, ibdp,ap,ssat,sat,sat2课程辅导，国外大学本科硕士研究生博士课程论文辅导Cancel reply